These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [The effect of cyclophosphamide, thalidomide and dexamethasone combination therapy in relapsed/refractory multiple myeloma]. Gao W; An N; Chen SL Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):221-2. PubMed ID: 16624158 [TBL] [Abstract][Full Text] [Related]
64. Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system. Sirohi B; Powles R; Mehta J; Raje N; Kulkarni S; Ramiah V; Saso R; Horton C; Bhagwati N; Singhal S; Treleaven J Br J Haematol; 1999 Dec; 107(3):656-66. PubMed ID: 10583272 [TBL] [Abstract][Full Text] [Related]
65. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685 [TBL] [Abstract][Full Text] [Related]
66. Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma. Leonard RC; Lucraft HH; Proctor SJ; Allan NC; Dawson AA; Leonard RC; Lucraft HH; McGillivray JB; Parker AC; Prescott RJ Scott Med J; 1988 Dec; 33(6):360-2. PubMed ID: 3245016 [TBL] [Abstract][Full Text] [Related]
67. Multi-drug combination therapy with vincristine-melphalan-cyclophosphamide-prednisolone was more effective than cyclophosphamide-prednisolone in stage III myeloma. The Nagoya Myeloma Cooperative Study Group. Shimizu K; Kamiya O; Hamajima N; Mizuno H; Kobayashi M; Hirabayashi N; Takeyama H; Kato R; Kawashima K; Nitta M Jpn J Cancer Res; 1990 Dec; 81(12):1320-7. PubMed ID: 2126002 [TBL] [Abstract][Full Text] [Related]
68. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer]. Schalhorn A Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699 [No Abstract] [Full Text] [Related]
69. Alternating appearance of IgD and IgG myeloma protein during treatment. Oxelius VA Scand J Haematol; 1971; 8(6):439-45. PubMed ID: 5160304 [No Abstract] [Full Text] [Related]
70. Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma. Petrucci MT; Avvisati G; La Verde G; De Fabritiis P; Ribersani M; Palumbo G; De Felice L; Rusignuolo A; Simone F; Meloni G; Mandelli F Acta Haematol; 2003; 109(4):184-8. PubMed ID: 12853690 [TBL] [Abstract][Full Text] [Related]
71. A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma. Becker PS; Gooley TA; Green DJ; Burwick N; Kim TY; Kojouri K; Inoue Y; Moore DJ; Nelli E; Dennie T; Bensinger WI Blood Cancer J; 2016 May; 6(5):e422. PubMed ID: 27176798 [No Abstract] [Full Text] [Related]
72. Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon. Kobayashi T; Sato Y; Hasegawa Y; Nagasawa T; Yoda Y; Abe T Intern Med; 1992 Jul; 31(7):936-40. PubMed ID: 1450506 [TBL] [Abstract][Full Text] [Related]
73. Myeloma presenting during pregnancy. Smith D; Stevens J; Quinn J; Cavenagh J; Ingram W; Yong K Hematol Oncol; 2014 Mar; 32(1):52-5. PubMed ID: 23996410 [No Abstract] [Full Text] [Related]
74. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group. Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904 [TBL] [Abstract][Full Text] [Related]
75. Thalidomide for the treatment of leptomeningeal multiple myeloma. Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710 [No Abstract] [Full Text] [Related]
76. [Combination chemotherapy of adult T-cell leukemia (ATL) using cyclophosphamide, vindesine and prednisolone (CV'P)]. Makino T; Uozumi K; Shimazaki T; Otsuka M; Kuwazuru Y; Saito T; Utsunomiya A; Hanada S; Hashimoto S Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2657-62. PubMed ID: 3249106 [No Abstract] [Full Text] [Related]
77. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma. McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419 [TBL] [Abstract][Full Text] [Related]
78. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma]. Takagi T; Oguro M; Sakai C Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977 [No Abstract] [Full Text] [Related]
79. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486. Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521 [TBL] [Abstract][Full Text] [Related]